Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Repligen Raises FY2025 Adj EPS Guidance from $1.63-$1.72 to $1.65-$1.72 vs $1.68 Est; Raises FY2025 Sales Guidance from $695.000M-$720.000M to $715.000M-$735.000M vs $709.438M Est

Author: Benzinga Newsdesk | July 29, 2025 07:33am
Repligen (NASDAQ:RGEN) raises FY2025 Adj EPS guidance from $1.63-$1.72 to $1.65-$1.72 vs $1.68 analyst estimate. Raises FY2025 sales outlook from $695.000 million-$720.000 million to $715.000 million-$735.000 million vs $709.438 million estimate.

Posted In: RGEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist